Type 2 Diabetes
Showing NaN - NaN of 69
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)
Recruiting
- Type 2 Diabetes
- +5 more
- Orforglipron
- Insulin Glargine
-
Muscle Shoals, Alabama
- +320 more
Apr 12, 2023
Colorectal Cancer, Type 2 Diabetes Trial in Los Angeles (Intervention Group (IG))
Not yet recruiting
- Colorectal Cancer
- Type 2 Diabetes
- Intervention Group (IG)
-
Los Angeles, CaliforniaCharles R. Drew University
Mar 10, 2023
Pediatric Obesity, Type 2 Diabetes, Time Restricted Eating Trial in Los Angeles (Time Limited Eating, Components Common to All
Not yet recruiting
- Pediatric Obesity
- +2 more
- Time Limited Eating
- +3 more
-
Los Angeles, CaliforniaChildren's Hospital of Los Angeles
Nov 15, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)
Not yet recruiting
- Type 2 Diabetes
- Tirzepatide
- Antihyperglycemic medication
-
Birmingham, Alabama
- +96 more
Aug 8, 2022
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, LantusĀ®)
Type 2 Diabetes Trial in Australia, China, United States (INS068 injection, Insulin Degludec)
Active, not recruiting
- Type 2 Diabetes
- INS068 injection
- Insulin Degludec
-
Huntington Park, California
- +32 more
Jan 27, 2022
TODAY2 Phase 2 Follow-up
Completed
- Type 2 Diabetes
- TODAY cohort
-
Los Angeles, California
- +14 more
Jul 29, 2021
TODAY Genetics Study
Completed
- Type 2 Diabetes
-
Little Rock, Arkansas
- +24 more
Jul 28, 2021
Type 2 Diabetes, Obesity Trial in Los Angeles, London Village (Sugar-reduction intervention)
Completed
- Type 2 Diabetes
- Obesity
- Sugar-reduction intervention
-
Los Angeles, California
- +1 more
Mar 24, 2020
Hyperuricemia, Albuminuria, Type 2 Diabetes Trial in United States (Verinurad 9 mg+Febuxostat 80 mg, Placebo)
Completed
- Hyperuricemia
- +2 more
- Verinurad 9 mg+Febuxostat 80 mg
- Placebo
-
Canyon Country, California
- +17 more
Dec 18, 2019
Prediabetes, Type 2 Diabetes, Obesity Trial in Los Angeles (Metformin, gastric banding)
Completed
- Prediabetes
- +2 more
- Metformin
- gastric banding
-
Los Angeles, CaliforniaUniversity of Southern California
Oct 15, 2019
Type 2 Diabetes Trial in Los Angeles (Liraglutide)
Withdrawn
- Type 2 Diabetes
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Sep 26, 2019